Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsBusinessEarningsAurobindo Pharma FY11 PAT seen dn 0.35% at Rs 561 cr

    Aurobindo Pharma FY11 PAT seen dn 0.35% at Rs 561 cr

    Aurobindo Pharma is to announce its FY11 revenues are seen up 20% at Rs 4276 crore versus Rs 3575 crore.

    May 09, 2011 / 17:28 IST

    Aurobindo Pharma is to announce its FY11 revenues are seen up 20% at Rs 4276 crore versus Rs 3575 crore.

    Its EBITDA is seen up 16% to Rs 955 crore versus Rs 823 crore.

    The company's OPM is seen down 22.3% versus 23%.

    The company's PAT is seen down 0.35% at Rs 561 crore versus Rs 563 crore.

    first published: May 9, 2011 05:26 pm

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347